| Total | Progressor | |||
---|---|---|---|---|---|
DM/non-DM (O1/O2) | DM | Non-DM | P | OR (95% CI) | |
Patients | 36/62 | 26 (72.2) | 25 (40.3) | 0.002 | 3.85 (1.58–9.36) |
Vessels/segments | |||||
 LM | 33/58 | 8 (24.2) | 3 (5.2) | 0.007 | 5.86 (1.43–23.99) |
 LAD | 11/25 | 6 (54.5) | 10 (40) | 0.483 | 1.80 (0.43–7.53) |
  LAD1 | 18/39 | 6 (33.3) | 2 (5.1) | 0.009 | 9.25 (1.64–52.06) |
  LAD2 | 16/32 | 2 (12.5) | 7 (21.9) | 0.697 | 0.51 (0.09–2.80) |
  LAD3 | 28/54 | 2 (7.1) | 4 (7.4) | 1 | 0.96 (0.16–5.60) |
  D1 | 36/62 | 4 (11.1) | 1 (1.6) | 0.059 | 7.63 (0.82–71.10) |
  D2 | 36/62 | 2 (5.6) | 0 (0) | 0.133 | – |
 RCA | 18/38 | 9 (50) | 8 (21.1) | 0.028 | 3.75 (1.12–12.56) |
  RCA1 | 22/48 | 5 (22.7) | 3 (6.3) | 0.098 | 4.41 (0.95–20.50) |
  RCA2 | 25/46 | 4 (16.0) | 2 (4.3) | 0.175 | 4.19 (0.71–24.73) |
  RCA3 | 32/57 | 6 (18.8) | 7 (12.3) | 0.533 | 1.65 (0.50–5.41) |
  r-PDA | 36/62 | 0 | 0 | – | – |
  r-PLB | 36/61 | 1 (2.8) | 1 (1.6) | 1 | 1.71 (0.10–28.28) |
 LCx | 26/44 | 7 (26.9) | 4 (9.1) | 0.085 | 3.68 (0.96–14.13) |
  LCx1 | 29/54 | 4 (13.8) | 5 (9.3) | 0.713 | 1.57 (0.39–6.36) |
  LCx2 | 30/49 | 6 (20) | 2 (4.1) | 0.048 | 5.89 (1.10–31.34) |
  OM1 | 36/62 | 0 | 1 (1.6) | 1 | – |
  OM2 | 36/62 | 0 | 0 | – | – |
  L-PDA | 36/62 | 0 | 0 | – | – |
Plaque type | |||||
 Calcified plaque | 54/106 | 10 (18.5) | 11 (10.4) | 0.149 | 1.96 (0.78–4.97) |
 Non-calcified plaque | 45/78 | 14 (31.1) | 10 (12.8) | 0.014 | 3.07 (1.23–7.68) |
Original extent score | |||||
 0 | 362/709 | 24 (6.6) | 21 (3.0) | 0.005 | 2.33 (1.28–4.24) |
 1 | 17/27 | 8 (47.1) | 5 (18.5) | 0.043 | 3.91 (1.00–15.24) |
 2 | 62/117 | 9 (14.5) | 11 (9.4) | 0.301 | 1.64 (0.64–4.19) |
 3 | 15/23 | 6 (40) | 3 (13.0) | 0.128 | 4.44 (0.90–21.87) |
 4 | 4/10 | 1 (25.0) | 0 (0) | 0.286 | 0.23 (0.09–0.62) |